We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-29.74%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$243M
AUM Growth
-$369M
Cap. Flow
-$216M
Cap. Flow %
-88.84%
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94

Top Buys

Rank Stock Value
1
OXSQ icon
Oxford Square Capital
OXSQ
+$1.88M
2
NEM icon
Newmont
NEM
+$1.81M
3
BEP icon
Brookfield Renewable
BEP
+$1.69M
4
XRN
Chiron Real Estate Inc
XRN
+$1.68M
5
PSA icon
Public Storage
PSA
+$1.65M

Top Sells

Rank Stock Value
1
RS icon
Reliance Steel & Aluminium
RS
+$4.3M
2
VALE icon
Vale
VALE
+$4.14M
3
DEA
Easterly Government Properties
DEA
+$4.07M
4
NP
Neenah, Inc. Common Stock
NP
+$4.04M
5
ABR icon
Arbor Realty Trust
ABR
+$3.91M

Sector Composition

Rank Sector Weight
1 Financials 20.56%
2 Healthcare 19.87%
3 Real Estate 12.49%
4 Energy 9.44%
5 Materials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPTX
226
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$290K 0.12%
6,498
-946
-13% -$50.2K
XNCR icon
227
Xencor
XNCR
$1.59B
$288K 0.12%
9,633
-1,401
-13% -$46.4K
TVRD
228
Tvardi Therapeutics
TVRD
$19.7M
$287K 0.12%
603
-88
-13% -$47.8K
CNST
229
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$287K 0.12%
9,122
-1,343
-13% -$46.7K
BBIO icon
230
BridgeBio Pharma
BBIO
$16.1B
$286K 0.12%
9,860
-1,435
-13% -$44.5K
GERN icon
231
Geron
GERN
$860M
$285K 0.12%
239,698
-34,960
-13% -$42.8K
BPMC
232
DELISTED
Blueprint Medicines
BPMC
$283K 0.12%
4,836
-704
-13% -$45.3K
STML
233
DELISTED
Stemline Therapeutics, Inc.
STML
$283K 0.12%
58,544
-4,940
-8% -$32K
AMRS
234
DELISTED
Amyris Inc.
AMRS
$282K 0.12%
110,292
-16,080
-13% -$46.9K
PRVB
235
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$282K 0.12%
30,657
-4,461
-13% -$57.5K
EIDX
236
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$278K 0.11%
5,667
-814
-13% -$41.5K
PGNX
237
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$273K 0.11%
71,758
-10,475
-13% -$45.1K
AIMT
238
DELISTED
Aimmune Therapeutics
AIMT
$271K 0.11%
18,800
-1,586
-8% -$40.5K
KOD icon
239
Kodiak Sciences
KOD
$2.66B
$270K 0.11%
5,667
-834
-13% -$50K
QTTB icon
240
Q32 Bio
QTTB
$462M
$270K 0.11%
964
-142
-13% -$43.5K
SGMO
241
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$269K 0.11%
42,254
-6,154
-13% -$45.7K
WES icon
242
Western Midstream Partners
WES
$19.6B
$269K 0.11%
83,040
-53,336
-39% -$734K
KYNB
243
Kyntra Bio
KYNB
$27.5M
$268K 0.11%
308
-45
-13% -$44.7K
RGNX icon
244
Regenxbio
RGNX
$648M
$267K 0.11%
8,236
-1,200
-13% -$50K
ALLO icon
245
Allogene Therapeutics
ALLO
$680M
$258K 0.11%
13,279
-1,935
-13% -$46.1K
NXTC icon
246
NextCure
NXTC
$20.5M
$257K 0.11%
578
-83
-13% -$44.3K
TECX
247
Tectonic Therapeutic
TECX
$538M
$256K 0.11%
1,370
-199
-13% -$46.9K
RIGL icon
248
Rigel Pharmaceuticals
RIGL
$704M
$252K 0.1%
16,124
-2,350
-13% -$50K
MYOK
249
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$252K 0.1%
5,383
-791
-13% -$50.7K
RETA
250
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$251K 0.1%
1,738
-254
-13% -$49K
8 9
10
11 12

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM

Virtus ETF Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, Virtus ETF Advisers held 504 positions worth $243M, down 60% from $612M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Virtus ETF Advisers withdrew a net $216M in Q1 2020, closing 94 positions and reducing 307 holdings. Its most notable exit was Reliance Steel & Aluminium, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Virtus ETF Advisers opened a new position in Newmont worth $1.82M.

  • Virtus ETF Advisers's largest Q1 2020 buy was Newmont: 40,138 shares worth $1.82M.
  • Virtus ETF Advisers added most to Oxford Square Capital in Q1 2020, an estimated $1.88M increase.
  • Virtus ETF Advisers's biggest Q1 2020 reduction was Air Products & Chemicals, cutting an estimated $3.72M.
  • Virtus ETF Advisers fully exited Reliance Steel & Aluminium in Q1 2020, selling an estimated $4.3M.
  • Virtus ETF Advisers's ten largest holdings make up 9.9% of its $243M portfolio in Q1 2020.
  • Virtus ETF Advisers opened 52 new positions and closed 94 in Q1 2020.
  • Virtus ETF Advisers's portfolio value fell 60% quarter-over-quarter to $243M.

Based on Virtus ETF Advisers's 13F filing for Q1 2020, filed 14 May 2020.